Furthermore, several genome-wide association (GWAS) studies identified multiple AD-risk genes that could be linked with the Aβ cascade and/or tau pathology, but also to cholesterol and lipid metabolism, immune system and inflammatory response, and vesicle trafficking [20,21,22]. Here, MAPT is linked to Alzheimer disease.